Total Payments
$69,017
2024 Payments
$1,718
Companies
49
Transactions
679
Medicare Patients
21,146
Medicare Billing
$1.6M
Payment Breakdown by Category
Other$30,969 (44.9%)
Travel$15,186 (22.0%)
Food & Beverage$14,831 (21.5%)
Consulting$6,533 (9.5%)
Education$940.25 (1.4%)
Research$558.15 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,969 | 12 | 44.9% |
| Travel and Lodging | $15,186 | 47 | 22.0% |
| Food and Beverage | $14,831 | 573 | 21.5% |
| Consulting Fee | $6,533 | 5 | 9.5% |
| Education | $940.25 | 37 | 1.4% |
| Unspecified | $558.15 | 5 | 0.8% |
Payments by Type
General
$68,459
674 transactions
Research
$558.15
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ferring Pharmaceuticals Inc. | $31,067 | 73 | $0 (2024) |
| Allergan, Inc. | $13,801 | 47 | $0 (2022) |
| Avadel Specialty Pharmaceuticals, LLC | $9,614 | 18 | $0 (2019) |
| NeoTract Inc. | $2,174 | 23 | $0 (2020) |
| Astellas Pharma US Inc | $1,285 | 55 | $0 (2024) |
| Janssen Biotech, Inc. | $1,018 | 42 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $954.11 | 40 | $0 (2024) |
| ABBVIE INC. | $849.13 | 43 | $0 (2024) |
| Medtronic USA, Inc. | $837.86 | 6 | $0 (2020) |
| Endo Pharmaceuticals Inc. | $747.80 | 53 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,718 | 63 | Janssen Biotech, Inc. ($279.86) |
| 2023 | $2,599 | 95 | Sumitomo Pharma America, Inc. ($332.00) |
| 2022 | $1,626 | 65 | Astellas Pharma US Inc ($303.84) |
| 2021 | $966.82 | 47 | Medtronic, Inc. ($165.31) |
| 2020 | $11,178 | 38 | Ferring Pharmaceuticals Inc. ($10,060) |
| 2019 | $32,404 | 130 | Ferring Pharmaceuticals Inc. ($20,854) |
| 2018 | $12,374 | 136 | Avadel Specialty Pharmaceuticals, LLC ($9,507) |
| 2017 | $6,151 | 105 | Allergan Inc. ($4,458) |
All Payment Transactions
679 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $33.55 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/12/2024 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $20.25 | General |
| 12/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: HORMONE THERAPY | ||||||
| 12/03/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $53.40 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/03/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/25/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/07/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: HORMONE THERAPY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: HORMONE THERAPY | ||||||
| 10/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: UROLOGY | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/11/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $49.37 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/11/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: HORMONE THERAPY | ||||||
| 09/09/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $19.85 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 09/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Oncology | ||||||
| 08/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Oncology | ||||||
| 08/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/29/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE TREATMENT, 2-STAGE, DOSE FINDING STUDY EVALUATING THE EFFICACY AND SAFETY OF BOTOX INTRAVESICAL INSTALLATION IN PARTICIPANTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE. | Allergan Inc. | $558.15 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 5,511 | 13,474 | $1.4M | $344,660 |
| 2022 | 46 | 4,817 | 11,278 | $1.6M | $337,774 |
| 2021 | 58 | 5,785 | 18,483 | $2.2M | $515,621 |
| 2020 | 50 | 5,033 | 16,926 | $1.8M | $424,537 |
Total Patients
21,146
Total Services
60,161
Medicare Billing
$1.6M
Procedure Codes
195
All Medicare Procedures & Services
195 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 588 | 1,087 | $340,122 | $84,625 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 370 | 526 | $232,013 | $58,106 | 25.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 95 | 112 | $108,952 | $25,714 | 23.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 24 | 3,800 | $67,830 | $18,760 | 27.7% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 76 | 76 | $72,496 | $17,519 | 24.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 743 | 1,580 | $74,769 | $16,109 | 21.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 99 | 100 | $49,506 | $13,201 | 26.7% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 24 | 33 | $46,129 | $12,561 | 27.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 320 | 445 | $24,551 | $8,001 | 32.6% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 135 | 142 | $29,777 | $7,731 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 75 | 75 | $29,549 | $7,219 | 24.4% |
| 64561 | Insertion of sacral nerve neurostimulator electrode array | Facility | 2023 | 13 | 19 | $50,590 | $7,004 | 13.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 768 | 1,862 | $19,439 | $6,282 | 32.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 452 | 736 | $6,624 | $6,098 | 92.1% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 17 | 17 | $22,189 | $6,083 | 27.4% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 364 | 455 | $71,560 | $5,735 | 8.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 83 | 86 | $19,840 | $5,187 | 26.1% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 316 | 542 | $13,122 | $4,287 | 32.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $12,054 | $3,182 | 26.4% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 35 | 43 | $25,500 | $3,036 | 11.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $10,993 | $2,880 | 26.2% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 15 | 15 | $10,367 | $2,842 | 27.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 11 | 46 | $10,118 | $2,774 | 27.4% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 98 | 312 | $8,096 | $2,644 | 32.7% |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | Office | 2023 | 32 | 43 | $8,618 | $2,253 | 26.1% |
About Dr. Alfred Kohan, MD
Dr. Alfred Kohan, MD is a Urology healthcare provider based in Plainview, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831152768.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alfred Kohan, MD has received a total of $69,017 in payments from pharmaceutical and medical device companies, with $1,718 received in 2024. These payments were reported across 679 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,969).
As a Medicare-enrolled provider, Kohan has provided services to 21,146 Medicare beneficiaries, totaling 60,161 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 195 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Plainview, NY
- Active Since 04/11/2006
- Last Updated 04/02/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1831152768
Products in Payments
- NOCDURNA (Drug) $30,868
- Noctiva (Drug) $9,614
- BOTOX COSMETIC (Biological) $7,544
- BOTOX (Biological) $5,081
- UROLIFT (Device) $1,566
- XTANDI (Drug) $836.83
- BOTOX (Drug) $685.29
- INTERSTIM (Device) $648.73
- ERLEADA (Drug) $639.85
- PROVENGE (Drug) $624.98
- UroLift (Device) $624.88
- ORGOVYX (Drug) $591.89
- Xofigo (Drug) $575.42
- XIAFLEX (Biological) $541.78
- GEMTESA (Drug) $460.27
- SPEEDICATH (Device) $424.48
- Nubeqa (Drug) $378.69
- Erleada (Drug) $372.25
- Androgel (Drug) $314.29
- BOTOX OAB (Drug) $309.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Plainview
Theodore Felderman, Md, MD
Urology — Payments: $12,450
Urology $12,450
Jeffrey Layne, Md, MD
Urology — Payments: $4,391
Urology $4,391
Dr. Jeffrey Haberman, Md, MD
Urology — Payments: $3,717
Urology $3,717
Robert Luntz, Md, MD
Urology — Payments: $3,257
Urology $3,257
Dr. Tso-Jen Hsiao, M.d, M.D
Urology — Payments: $352.10
Urology $352.10
Dr. Elliott Lieberman, M.d, M.D
Urology — Payments: $349.79
Urology $349.79